Đang chuẩn bị liên kết để tải về tài liệu:
Signaling protein signature predicts clinical outcome of non-small-cell lung cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Non-small-cell lung cancer (NSCLC) is characterized by abnormalities of numerous signaling proteins that play pivotal roles in cancer development and progression. Many of these proteins have been reported to be correlated with clinical outcomes of NSCLC. | Signaling protein signature predicts clinical outcome of non-small-cell lung cancer

TÀI LIỆU LIÊN QUAN

Regulator of G protein signaling 17 as a negative modulator of GPCR signaling in multiple human cancers

PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways

The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling

Regulator of G-protein Signaling (RGS)1 and RGS10 proteins as potential drug targets for neuroinflammatory and neurodegenerative diseases

Conditional disruption of interactions between Gαi2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injury

Ebook Proteomics and protein-protein interactions: Biology, chemistry, bioinformatics, and drug design

Ebook Proteomics and protein-protein interactions: Biology, chemistry, bioinformatics, and drug design

PROTEIN PHOSPHORYLATION IN HUMAN HEALTH

Genetic polymorphisms in bone morphogenetic protein receptor type IA gene predisposes individuals to ossification of the posterior longitudinal ligament of the cervical spine via the smad signaling pathway

Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: A case study on M. tuberculosis